28/07/2026
🌍 World Hepatitis Day 2026
Break the Silence. Expand Hepatitis Screening.
Hepatitis remains a global health challenge, and many infections may go unnoticed without timely screening. Early detection plays an essential role in supporting healthcare decisions, improving disease management, and strengthening public health initiatives.
On World Hepatitis Day 2026, AccuBioTech highlights the importance of accessible and reliable hepatitis testing solutions that help healthcare professionals identify risks earlier and support better health outcomes.
Through the Accu-Tell® Comprehensive Hepatitis Rapid Testing Portfolio, we provide flexible diagnostic solutions covering:
🔹 Hepatitis A (HAV)
Antibody detection solutions supporting Hepatitis A screening.
🔹 Hepatitis B (HBV)
Comprehensive serology testing solutions covering key HBV markers.
🔹 Hepatitis C (HCV)
Accessible Anti-HCV screening solutions for diverse healthcare settings.
🔹 Multi-Marker Combo Testing
Integrated screening solutions supporting efficient infectious disease testing.
Designed for real-world healthcare needs, Accu-Tell® solutions offer:
✓ Comprehensive HAV, HBV & HCV coverage
✓ Flexible strip and cassette formats
✓ Multiple sample options
✓ Reliable rapid diagnostic performance
From local clinics to global healthcare programs, AccuBioTech remains committed to making reliable diagnostics more accessible worldwide.
Together, let’s promote awareness, encourage early screening, and support a healthier future.
Accu-Tell® — Accurate. Reliable. Accessible.